A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2018; you can also visit <a rel="external noopener" href="https://jcmr-online.biomedcentral.com/track/pdf/10.1186/1532-429X-11-S1-P267?site=jcmr-online.biomedcentral.com">the original URL</a>. The file type is <code>application/pdf</code>.
<i title="Springer Nature">
<a target="_blank" rel="noopener" href="https://fatcat.wiki/container/jflzecjifjfnzmksqbreqnmoo4" style="color: black;">Journal of Cardiovascular Magnetic Resonance</a>
Journal of Cardiovascular Magnetic Resonance 2009, 11(Suppl 1):O1 Introduction: Prophylactic implantation of a cardioverter/ defibrillator (ICD) has been shown to reduce mortality in patients with chronic myocardial infarction (CMI) and an increased risk for life threatening ventricular arrhythmia (VA). The use of ICDs in this large patient population is still limited by high costs and possible adverse events including inappropriate discharges and progression of heart failure. VA is related to<span class="external-identifiers"> <a target="_blank" rel="external noopener noreferrer" href="https://doi.org/10.1186/1532-429x-11-s1-p267">doi:10.1186/1532-429x-11-s1-p267</a> <a target="_blank" rel="external noopener" href="https://fatcat.wiki/release/6ylmd7qllza5ximrxmdf2yxy5i">fatcat:6ylmd7qllza5ximrxmdf2yxy5i</a> </span>
more »... nfarct size and seems to be related to infarct morphology. Contrast enhanced cardiovascular magnetic resonance imaging (ceCMR) can detect and quantify myocardial fibrosis in the setting of CMI and might therefore be a valuable tool for a more accurate risk stratification in this setting. Hypothesis: ceCMR can identify the subgroup developing VA in patients with prophylactic ICD implantation following MADIT criteria. Methods: We prospectively enrolled 52 patients (49 males, age 69 ± 10 years) with CMI and clinical indication for ICD therapy following MADIT criteria. Prior to implantation (36 ± 78 days) patients were investigated on a 1.5 T clinical scanner (Siemens Avanto © , Germany) to assess left ventricular function (LVEF), LV end-diastolic volume (LVEDV) and LV mass (sequence parameters: GRE SSFP, matrix 256 × 192, short axis stack; full LV coverage, no gap; slice thickness 6 mm). For quantitative assessment of infarct morphology late gadolinium enhancement (LGE) was performed including measurement of total and relative infarct mass (related to LV mass) and the degree of transmurality (DT) as defined by the percentage of transmurality in each scar. (sequence parameters: inversion recovery gradient echo; matrix 256 × 148, imaging 10 min after 0.2 μg/kg gadolinium DTPA; slice orientation equal to SSFP). MRI images were analysed using dedicated software (MASS © , Medis,
<a target="_blank" rel="noopener" href="https://web.archive.org/web/20180720073904/https://jcmr-online.biomedcentral.com/track/pdf/10.1186/1532-429X-11-S1-P267?site=jcmr-online.biomedcentral.com" title="fulltext PDF download" data-goatcounter-click="serp-fulltext" data-goatcounter-title="serp-fulltext"> <button class="ui simple right pointing dropdown compact black labeled icon button serp-button"> <i class="icon ia-icon"></i> Web Archive [PDF] </button> </a> <a target="_blank" rel="external noopener noreferrer" href="https://doi.org/10.1186/1532-429x-11-s1-p267"> <button class="ui left aligned compact blue labeled icon button serp-button"> <i class="unlock alternate icon" style="background-color: #fb971f;"></i> springer.com </button> </a>